Physical Mapping of HIV Reverse Transcriptase to the 5′ End of RNA Primers

Enzymatic analysis of RNA cleavage products has suggested that human immunodeficiency virus (HIV) reverse transcriptase (RT) binds to the 5′ end of RNAs that are recessed on a longer DNA template (RNA primers) yet binds to the 3′ end of DNA primers. One concern is that RT molecules bound at the 3′ e...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 276; no. 35; pp. 32515 - 32521
Main Authors DeStefano, Jeffrey J., Cristofaro, Jason V., Derebail, Suchitra, Bohlayer, William P., Fitzgerald-Heath, Megan J.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 31.08.2001
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Enzymatic analysis of RNA cleavage products has suggested that human immunodeficiency virus (HIV) reverse transcriptase (RT) binds to the 5′ end of RNAs that are recessed on a longer DNA template (RNA primers) yet binds to the 3′ end of DNA primers. One concern is that RT molecules bound at the 3′ end of RNA would not be easily detected because RT may not catalyze substantial RNA extension or cleavage when bound to the 3′ end. We used physical mapping to show that RT binds preferentially to the 5′ end of RNA primers. An HIV-RT that lacked RNase H activity (HIV-RTE478Q) was incubated with the RNA-DNA hybrid followed by the addition of Escherichia coli RNase H. RT protected a ∼23-base region at the 5′ end of the RNA and 4 additional bases on the DNA strand. This footprint correlated well with the crystal structure of HIV-RT. No protection of the RNA 3′ end was observed, although when dNTPs were included, low levels of extension occurred, indicating that RT can bind this end. Wild-type HIV-RT cleaved the RNA and then extended a small portion of the cleaved fragments, suggesting that very small RNAs may be bound similar to DNA primers.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M103958200